Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana C Puhl

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry|October 8, 2022
Multiple approaches to repurposing drugs for neuroblastomaLaura Rank, Ana C Puhl, Tammy M Havener, et al.
International Journal of Biological Macromolecules|June 20, 2019
Crystallographic structure and molecular dynamics simulations of the major endoglucanase from Xanthomonas campestris pv. campestris shed light on its oligosaccharide products release patternAna C Puhl, Erica T Prates, Flávio R Rosseto, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 30, 2018
Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase InhibitorsAna C Puhl-Rubio, Michael A Stashko, Huanchen Wang, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Discovery and Development of Cyclic Peptide Inhibitors of CIB1Victoria A Haberman, Steven R Fleming, Tina M Leisner, et al.
Nuclear Receptor Signaling|October 8, 2015
Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugsAna C Puhl, Flora A Milton, Aleksandra Cvoro, et al.
Molecular Pharmacology|March 7, 2012
Mode of peroxisome proliferator-activated receptor γ activation by luteolinAna C Puhl, Amanda Bernardes, Rodrigo L Silveira, et al.
Drug Discovery Today|April 23, 2020
Déjà vu: Stimulating open drug discovery for SARS-CoV-2Sean Ekins, Melina Mottin, Paulo R P S Ramos, et al.
Tuberculosis (Edinburgh, Scotland)|March 3, 2024
Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessusJeremy J Yang, Aaron Goff, David J Wild, et al.
ACS Chemical Biology|May 9, 2020
Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1Ana C Puhl, Jonathan W Bogart, Victoria A Haberman, et al.
Plos Pathogens|January 10, 2023
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virusCameron Adams, Derek L Carbaugh, Bo Shu, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|October 8, 2022
Multiple approaches to repurposing drugs for neuroblastomaLaura Rank, Ana C Puhl, Tammy M Havener, et al.
International Journal of Biological Macromolecules|June 20, 2019
Crystallographic structure and molecular dynamics simulations of the major endoglucanase from Xanthomonas campestris pv. campestris shed light on its oligosaccharide products release patternAna C Puhl, Erica T Prates, Flávio R Rosseto, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 30, 2018
Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase InhibitorsAna C Puhl-Rubio, Michael A Stashko, Huanchen Wang, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Discovery and Development of Cyclic Peptide Inhibitors of CIB1Victoria A Haberman, Steven R Fleming, Tina M Leisner, et al.
Nuclear Receptor Signaling|October 8, 2015
Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugsAna C Puhl, Flora A Milton, Aleksandra Cvoro, et al.
Molecular Pharmacology|March 7, 2012
Mode of peroxisome proliferator-activated receptor γ activation by luteolinAna C Puhl, Amanda Bernardes, Rodrigo L Silveira, et al.
Drug Discovery Today|April 23, 2020
Déjà vu: Stimulating open drug discovery for SARS-CoV-2Sean Ekins, Melina Mottin, Paulo R P S Ramos, et al.
Tuberculosis (Edinburgh, Scotland)|March 3, 2024
Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessusJeremy J Yang, Aaron Goff, David J Wild, et al.
ACS Chemical Biology|May 9, 2020
Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1Ana C Puhl, Jonathan W Bogart, Victoria A Haberman, et al.
Plos Pathogens|January 10, 2023
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virusCameron Adams, Derek L Carbaugh, Bo Shu, et al.
Pageof 6